615 related articles for article (PubMed ID: 10972294)
1. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease).
Nishino I; Fu J; Tanji K; Yamada T; Shimojo S; Koori T; Mora M; Riggs JE; Oh SJ; Koga Y; Sue CM; Yamamoto A; Murakami N; Shanske S; Byrne E; Bonilla E; Nonaka I; DiMauro S; Hirano M
Nature; 2000 Aug; 406(6798):906-10. PubMed ID: 10972294
[TBL] [Abstract][Full Text] [Related]
2. Disease model: LAMP-2 enlightens Danon disease.
Saftig P; Tanaka Y; Lüllmann-Rauch R; von Figura K
Trends Mol Med; 2001 Jan; 7(1):37-9. PubMed ID: 11427988
[TBL] [Abstract][Full Text] [Related]
3. Autophagic vacuolar myopathy in twin girls.
Holton JL; Beesley C; Jackson M; Venner K; Bhardwaj N; Winchester B; Al-Memar A
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):253-9. PubMed ID: 16640643
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice.
Tanaka Y; Guhde G; Suter A; Eskelinen EL; Hartmann D; Lüllmann-Rauch R; Janssen PM; Blanz J; von Figura K; Saftig P
Nature; 2000 Aug; 406(6798):902-6. PubMed ID: 10972293
[TBL] [Abstract][Full Text] [Related]
5. Danon disease as a cause of autophagic vacuolar myopathy.
Yang Z; Vatta M
Congenit Heart Dis; 2007; 2(6):404-9. PubMed ID: 18377432
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic heterogeneity in two unrelated Danon patients associated with the same LAMP-2 gene mutation.
Bertini E; Donati MA; Broda P; Cassandrini D; Petrini S; Dionisi-Vici C; Ballerini L; Boldrini R; D'Amico A; Pasquini E; Minetti C; Santorelli FM; Bruno C
Neuropediatrics; 2005 Oct; 36(5):309-13. PubMed ID: 16217705
[TBL] [Abstract][Full Text] [Related]
7. Autophagic vacuolar myopathy.
Nishino I
Semin Pediatr Neurol; 2006 Jun; 13(2):90-5. PubMed ID: 17027858
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene.
Musumeci O; Rodolico C; Nishino I; Di Guardo G; Migliorato A; Aguennouz M; Mazzeo A; Messina C; Vita G; Toscano A
Neuromuscul Disord; 2005 Jun; 15(6):409-11. PubMed ID: 15907287
[TBL] [Abstract][Full Text] [Related]
9. Danon disease with typical early-onset cardiomyopathy in a male: focus on a novel LAMP-2 mutation.
Bui YK; Renella P; Martinez-Agosto JA; Verity A; Madikians A; Alejos JC
Pediatr Transplant; 2008 Mar; 12(2):246-50. PubMed ID: 18282207
[TBL] [Abstract][Full Text] [Related]
10. [Danon disease].
Nishino I
Ryoikibetsu Shokogun Shirizu; 2001; (36):225-9. PubMed ID: 11596375
[No Abstract] [Full Text] [Related]
11. Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease).
Lobrinus JA; Schorderet DF; Payot M; Jeanrenaud X; Bottani A; Superti-Furga A; Schlaepfer J; Fromer M; Jeannet PY
Neuromuscul Disord; 2005 Apr; 15(4):293-8. PubMed ID: 15792868
[TBL] [Abstract][Full Text] [Related]
12. Infantile autophagic vacuolar myopathy is distinct from Danon disease.
Yamamoto A; Morisawa Y; Verloes A; Murakami N; Hirano M; Nonaka I; Nishino I
Neurology; 2001 Sep; 57(5):903-5. PubMed ID: 11552028
[TBL] [Abstract][Full Text] [Related]
13. A 13-year-old girl with proximal weakness and hypertrophic cardiomyopathy with Danon disease.
Kim H; Cho A; Lim BC; Kim MJ; Kim KJ; Nishino I; Hwang YS; Chae JH
Muscle Nerve; 2010 Jun; 41(6):879-82. PubMed ID: 20513107
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel LAMP2 mutation responsible for X-chromosomal dominant Danon disease.
Horváth J; Ketelsen UP; Geibel-Zehender A; Boehm N; Olbrich H; Korinthenberg R; Omran H
Neuropediatrics; 2003 Jun; 34(5):270-3. PubMed ID: 14598234
[TBL] [Abstract][Full Text] [Related]
15. [Morphological and clinical aspects of Danon disease].
Fidziańska A; Walczak E; Walski M; Wiśniewska E; Wagner T; Kuch M
Kardiol Pol; 2008 Mar; 66(3):302-6. PubMed ID: 18393115
[TBL] [Abstract][Full Text] [Related]
16. Danon disease: an unusual presentation of autism.
Burusnukul P; de Los Reyes EC; Yinger J; Boué DR
Pediatr Neurol; 2008 Jul; 39(1):52-4. PubMed ID: 18555174
[TBL] [Abstract][Full Text] [Related]
17. Danon's disease (X-linked vacuolar cardiomyopathy and myopathy): a case with a novel Lamp-2 gene mutation.
Lacoste-Collin L; Garcia V; Uro-Coste E; Arné-Bes MC; Durand D; Levade T; Delisle MB
Neuromuscul Disord; 2002 Nov; 12(9):882-5. PubMed ID: 12398843
[TBL] [Abstract][Full Text] [Related]
18. Novel Lamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease.
Echaniz-Laguna A; Mohr M; Epailly E; Nishino I; Charron P; Richard P; Guiraud-Chaumeil C; Tranchant C
Muscle Nerve; 2006 Mar; 33(3):393-7. PubMed ID: 16372318
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of genetically confirmed Danon disease.
Sugie K; Yamamoto A; Murayama K; Oh SJ; Takahashi M; Mora M; Riggs JE; Colomer J; Iturriaga C; Meloni A; Lamperti C; Saitoh S; Byrne E; DiMauro S; Nonaka I; Hirano M; Nishino I
Neurology; 2002 Jun; 58(12):1773-8. PubMed ID: 12084876
[TBL] [Abstract][Full Text] [Related]
20. [Lysosomal glycogen storage disease with normal acid maltase (Danon) without apparent cardiomyopathy and mental retardation].
Kawamura H; Shimojo S; Nonaka I; Abe M; Tadokoro M
Rinsho Shinkeigaku; 2000 Mar; 40(3):259-62. PubMed ID: 10885338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
